TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: GDNF levels in breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100B levels in breastmilk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurable Residual Disease (MRD) negative Complete Remission rate by Next Generation Flow Cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurable Residual Disease (MRD) negative Complete Remission rate by FDG PET-CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects alive and not having developed respiratory failure
Endpoint domain: Mortality/survival
Primary endpoint: Trial Time for target identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success in psychophysical judgments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIH Stroke Scale - NIHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 10 Meter walk test / 10mwt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre handwriting skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limbal anterior chamber depth measurement agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total daily calories delivered/prescribed ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Desire to learn about fall prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Antibody levels above the defined cut-off
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Growth of intracranial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: optic nerve sheath diameter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of AI-assisted coronary CT angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of AI-assisted coronary CT angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical diagnosis of fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDRO prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: blood stream infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FLACC Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum C-reactive protein (CRP) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence and degree of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and degree of Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline using the Severity of Alopecia Tool (SALT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' score on the Expanded Disability Status Scale (EDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOA severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total hemoglobin (Total-Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: oxygenated hemoglobin (oxy-Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: deoxygenated hemoglobin (deoxy-Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participants' programme adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of sessions delivered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical efficacy outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oral symptoms associated with oral bullae, erosions and ulcerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to placement of neuraxial block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of passes to placement of neuraxial block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in CRQ-Dyspnea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in CRQ-Emotions Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect of sleep quality and mental state on early recurrence and prognosis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence rate of major vaccine-preventable infectious diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cytokine level analysis of synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cartilage biomarker analysis of synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak venous velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximum intensity of ICG fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first ICG fluorescence signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving 50% or greater improvement in facial Vitiligo Area Scoring Index (F)-VASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of early missed abortions
Endpoint domain: Mortality/survival
Primary endpoint: Number of termination of pregnancies
Endpoint domain: Mortality/survival
Primary endpoint: Total number and type of adverse events during EECP treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Total number and type of adverse events immediately following EECP treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Placental Netrin-1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-tidal Sevoflurane Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIBG-cardiac washout rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: patency and side branches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: aneurysm thrombosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pelvic asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Joints movement measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity of 68Ga-PSMA-11
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate defined as a POP-Q Aa <-2 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital anxiety signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion of joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of participants meeting Health Canada-approved indication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and feasibility of PET/CT imaging
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of thoracic hyper kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of forward head
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Need for soft tissue augmentation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Scar severity grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of T2DM patients with CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Re-epithelialization areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Complete burn wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Student's performance per clinical lab session
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NAPSI (Nail Psoriasis Severity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PASI (Psoriasis Area and Severity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: prevalence of CHIP mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of enrollment in skin care clinical study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gambling Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guidelines Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of tissue for single cell RNA sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Transverse diameter of the radial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of IgG anti Spike (UI/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in severity of attention deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion for SARS Cov-2 anti Spike antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants who develop inflammatory bowel disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with Adverse Events (AEs) and Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Fasting blood LDL cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to the Intermittent Fasting Regimen
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: change in total procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FAMily Engagement (FAME) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decision-making Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proton density fat fraction (PDFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: T2 relaxation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnetization Transfer Ratio (MTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood epilepsies and epileptic seizure management knowledge test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Epilepsy knowledge and attitude scale scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Satisfying Sexual Events (SSEs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sexual Risk-Taking
Endpoint domain: Adverse events/effects
Primary endpoint: Dating and Sexual Violence victimization
Endpoint domain: Adverse events/effects
Primary endpoint: Salivary LIGHT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Salivary IL-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Salivary IL-8 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: V'O2 peak during physical exercise protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial saturation of O2 during physical exercise protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of neurofilament light chain (NfL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with transitable colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Behavior towards chronic pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in MMP-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NOX2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TGF-β1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response (CR) rate or stringent CR (sCR)
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Concentration-time Curve From Time Zero Until the Last Observed Concentration (AUC0-t) of Fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated) (AUC0-inf) of Fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Observed Concentration (Cmax) of Fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suspected diagnosis rate of AIG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of IPD motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake Values (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrahepatic progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: self-transcendence scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dressing use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: LAA patency percentage associated with peri device leak (PDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LAA patency percentage associated with intra device leak (IDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of detected device-related thrombus (DRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Netherton Syndrome assessed by the Ichthyosis Area Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post-operative analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Result of Corona-T-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale (VAS) score
Endpoint domain: Adverse events/effects
Primary endpoint: Emotionalism After Recent Stroke
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social Adjustment Scale-Self-Report: Short Version (SAS-SR: Short) Change
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Recovering Quality of Life (ReQoL)-20 Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Return to Work Self-Efficacy Scale (RTW-SE) Change
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Quick Disabilities of Arm, Shoulder, Hand (QuickDASH) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of life on 14th day
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life on 30th day
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life on 90th day
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knowledge of Drug Effects and Brain Development
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of Substance Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readiness to Quit or Reduce Substance Use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Harm of Substance Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Operative Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Upper limb function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of hand dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMFM-88
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Renal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: AESI (hypersensitivity and loss of efficacy)
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery Quality of Life-20
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of moderate and severe pain after cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: Ankle Brachial Pressure score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of CSF Cryptococcus clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Conversion therapy success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of treatment side effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Radiographic or clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kappa Free Light Chain (KFLC) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty: Clinical Frailty Scale (CFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of obtention of adequate material for NGS testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients identifying genetic alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAQ-SS change at Month 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of children with PIBIS calculation and recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in enjoyment of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in perceived competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Resident Confidence Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resident Knowledge Survey
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Identification of Images
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in stroke severity and swallowing function (GUSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Changes in stroke severity and swallowing function (ROAG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Changes in stroke severity and swallowing function (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Reducing stroke-associated pneumonia (SAP) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: AUC ratio of clopidogrel active metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite Clinical Success (CCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Local Complications of Breast Reconstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening kidney allograft rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Birth weight of children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-inf) of MK-4318
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of MK-4318
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes